Literature DB >> 15564477

Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction.

Bernd Hauck1, Wei Zhao, Katherine High, Weidong Xiao.   

Abstract

Adeno-associated virus (AAV) is a unique gene transfer vector which takes approximately 4 to 6 weeks to reach its expression plateau. The mechanism for this slow-rise expression profile was proposed to be inefficient second-strand DNA synthesis from the input single-stranded (ss) DNA viral genome. In order to clarify the status of ss AAV genomes, we generated AAV vectors labeled with bromodeoxyuridine (BrdU), a nucleotide analog that can be incorporated into the AAV genome and packaged into infectious virions. Since BrdU-DNA can be detected only by an anti-BrdU antibody when DNA is in an ss form, not in a double-stranded (ds) form, ss AAV genomes with BrdU can be readily tracked in situ. Although ss AAV DNA was abundant by Southern blot analysis, free ss AAV genomes were not detectable after AAV transduction by this new detection method. Further Southern blot analysis of viral DNA and virions revealed that ss AAV DNA was protected within virions. Extracted cellular fractions demonstrated that viral particles in host cells remained infectious. In addition, a significant amount of AAV genomes was degraded after AAV transduction. Therefore, we conclude that the amount of free ss DNA is not abundant during AAV transduction. AAV transduction is limited by the steps that affect AAV ss DNA release (i.e., uncoating) before second-strand DNA synthesis can occur. AAV ss DNA released from viral uncoating is either converted into ds DNA efficiently or degraded by cellular DNA repair mechanisms as damaged DNA. This study elucidates a mechanism that can be exploited to develop new strategies to improve AAV vector transduction efficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564477      PMCID: PMC533901          DOI: 10.1128/JVI.78.24.13678-13686.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Site-specific targeting of DNA plasmids to chromosome 19 using AAV cis and trans sequences.

Authors:  S M Young; W Xiao; R J Samulski
Journal:  Methods Mol Biol       Date:  2000

2.  High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.

Authors:  L Cao; Y Liu; M J During; W Xiao
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.

Authors:  J S Bartlett; R Wilcher; R J Samulski
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Separation of two types of adeno-associated virus particles containing complementary polynucleotide chains.

Authors:  K I Berns; S Adler
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103

6.  Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.

Authors:  S Sanlioglu; P K Benson; J Yang; E M Atkinson; T Reynolds; J F Engelhardt
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis.

Authors:  D M McCarty; P E Monahan; R J Samulski
Journal:  Gene Ther       Date:  2001-08       Impact factor: 5.250

8.  Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

Authors:  D Duan; Y Yue; Z Yan; J Yang; J F Engelhardt
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

9.  Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter.

Authors:  R M Kotin; J C Menninger; D C Ward; K I Berns
Journal:  Genomics       Date:  1991-07       Impact factor: 5.736

10.  Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo.

Authors:  L Zhong; W Li; Z Yang; L Chen; Y Li; K Qing; K A Weigel-Kelley; M C Yoder; W Shou; A Srivastava
Journal:  Gene Ther       Date:  2004-07       Impact factor: 5.250

View more
  31 in total

Review 1.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

2.  Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.

Authors:  Bernhard Mani; Claudia Baltzer; Noelia Valle; José M Almendral; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction.

Authors:  Jinhui Wang; Jing Xie; Hui Lu; Lingxia Chen; Bernd Hauck; Richard Jude Samulski; Weidong Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

Review 4.  Recombinant adeno-associated virus transduction and integration.

Authors:  Brian R Schultz; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-05-20       Impact factor: 11.454

5.  Functional analysis of the putative integrin recognition motif on adeno-associated virus 9.

Authors:  Shen Shen; Garrett E Berry; Ruth M Castellanos Rivera; Roland Y Cheung; Andrew N Troupes; Sarah M Brown; Tal Kafri; Aravind Asokan
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

6.  Single tyrosine mutation in AAV8 and AAV9 capsids is insufficient to enhance gene delivery to skeletal muscle and heart.

Authors:  Chunping Qiao; Zhenhua Yuan; Jianbin Li; Ruhang Tang; Juan Li; Xiao Xiao
Journal:  Hum Gene Ther Methods       Date:  2012-02       Impact factor: 2.396

7.  Unique glycan signatures regulate adeno-associated virus tropism in the developing brain.

Authors:  Giridhar Murlidharan; Travis Corriher; H Troy Ghashghaei; Aravind Asokan
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

8.  Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.

Authors:  Sarah C Nicolson; R Jude Samulski
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

9.  Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.

Authors:  Jarrod S Johnson; Chengwen Li; Nina DiPrimio; Marc S Weinberg; Thomas J McCown; R Jude Samulski
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

Review 10.  Gene therapy using adeno-associated virus vectors.

Authors:  Shyam Daya; Kenneth I Berns
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.